| SCHOLAR ROCK HLDG DL-,001 |
| USA |
| Gesundheit |
| US80706P1030 / A2JMQW |
| 2QK (Frankfurt) / SRRK (NASDAQ) |
| FRA:2QK, ETR:2QK, 2QK:GR, NASDAQ:SRRK |
| - |
| https://scholarrock.com/ |
|
Scholar Rock Holding Corporation is a biopharmaceutical company focused on developing innovative therapies for serious diseases. The company's primary function is to discover and advance treatments th..
>Volltext.. |
| 3822.42 Mio. EUR |
| 3601.59 Mio. EUR |
| - |
| -305.12 Mio. EUR |
| -299.16 Mio. EUR |
| -2.75 EUR |
| 93.17 Mio. EUR |
| 242.73 Mio. EUR |
| -231.97 Mio. EUR |
| 5.96 |
| - |
| -48.41% |
| - |
| - |
| - |
| SCHOLAR ROCK |
| 03.03.26 |